These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16603278

  • 1. Ethical analysis of HPV vaccine policy options.
    Zimmerman RK.
    Vaccine; 2006 May 29; 24(22):4812-20. PubMed ID: 16603278
    [Abstract] [Full Text] [Related]

  • 2. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE.
    Seton Hall Law Rev; 2009 May 29; 39(1):265-90. PubMed ID: 19288617
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
    Ault KA.
    Obstet Gynecol Surv; 2006 Jun 29; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HPV vaccine MedImmune/GlaxoSmithKline.
    Billich A.
    Curr Opin Investig Drugs; 2003 Feb 29; 4(2):210-3. PubMed ID: 12669384
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
    Shaw AR.
    Gynecol Oncol; 2005 Dec 29; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
    [Abstract] [Full Text] [Related]

  • 10. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Dec 29; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 11. Ethics and the HPV vaccine: considerations for school nurses.
    Bennett MP.
    J Sch Nurs; 2008 Oct 29; 24(5):275-83. PubMed ID: 18941151
    [Abstract] [Full Text] [Related]

  • 12. [Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?].
    Dillner J.
    Lakartidningen; 2003 Oct 23; 100(43):3390-1. PubMed ID: 14626766
    [No Abstract] [Full Text] [Related]

  • 13. Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
    Brown DR, Fife KH, Wheeler CM, Koutsky LA, Lupinacci LM, Railkar R, Suhr G, Barr E, Dicello A, Li W, Smith JF, Tadesse A, Jansen KU.
    Vaccine; 2004 Jul 29; 22(21-22):2936-42. PubMed ID: 15246630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.
    Hildesheim A, Markowitz L, Avila MH, Franceschi S.
    Vaccine; 2006 Aug 31; 24 Suppl 3():S3/227-32. PubMed ID: 16950011
    [Abstract] [Full Text] [Related]

  • 17. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.
    Dempsey AF, Zimet GD, Davis RL, Koutsky L.
    Pediatrics; 2006 May 31; 117(5):1486-93. PubMed ID: 16651301
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.